ECO Animal Health logo

EAH - ECO Animal Health Share Price

365p 0.0  0.0%

Last Trade - 4:10pm

Small Cap
Market Cap £247.1m
Enterprise Value £243.2m
Revenue £85.9m
Position in Universe 785th / 1826
Unlock EAH Revenue
Relative Strength (%)
1m +1.75%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.75%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
39.0 47.1 61.4 67.2 67.3 72.1 100.8 104.9 +13.1%
+58.0 +40.1 +74.7 -15.4 -22.8 -66.2 +201.2 +6.08
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, EcoAnimal Health Group Plc revenues increased 50% to £42.5M.Net income increased 86% to £2.1M. Revenues reflect Chinasegment increase from £5.6M to £20.8M, North Americasegment increase of 73% to £6.4M. Net income benefited fromOther income increase from £8K to £397K (income), Sharebased payments decrease of 59% to £85K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for EAH
Graphical History


EAH Revenue Unlock EAH Revenue

Net Income

EAH Net Income Unlock EAH Revenue

Normalised EPS

EAH Normalised EPS Unlock EAH Revenue

PE Ratio Range

EAH PE Ratio Range Unlock EAH Revenue

Dividend Yield Range

EAH Dividend Yield Range Unlock EAH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
EAH EPS Forecasts Unlock EAH Revenue
Profile Summary

Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated May 22, 1984
Public Since September 26, 1995
No. of Shareholders: n/a
No. of Employees: 204
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 67,704,416
Free Float (0.0%)
Eligible for
EAH Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for EAH
Upcoming Events for EAH
Monday 14th June, 2021 Estimate
Full Year 2021 ECO Animal Health Group PLC Earnings Release
Frequently Asked Questions for ECO Animal Health
What is the ECO Animal Health share price?

As of 4:10pm, shares in ECO Animal Health are trading at 365p, giving the company a market capitalisation of £247.1m. This share price information is delayed by 15 minutes.

How has the ECO Animal Health share price performed this year?

Shares in ECO Animal Health are currently trading at 365p and the price has moved by 64.04% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ECO Animal Health price has moved by 33.09% over the past year.

What are the analyst and broker recommendations for ECO Animal Health?

Of the analysts with advisory recommendations for ECO Animal Health, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for ECO Animal Health is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will ECO Animal Health next release its financial results?

ECO Animal Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the ECO Animal Health dividend yield?

ECO Animal Health does not currently pay a dividend.

Does ECO Animal Health pay a dividend?

ECO Animal Health does not currently pay a dividend.

When does ECO Animal Health next pay dividends?

ECO Animal Health does not currently pay a dividend.

How do I buy ECO Animal Health shares?

To buy shares in ECO Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ECO Animal Health?

Shares in ECO Animal Health are currently trading at 365p, giving the company a market capitalisation of £247.1m.

Where are ECO Animal Health shares listed? Where are ECO Animal Health shares listed?

Here are the trading details for ECO Animal Health:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: EAH
What kind of share is ECO Animal Health?

Based on an overall assessment of its quality, value and momentum, ECO Animal Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a ECO Animal Health share price forecast 2021?

Shares in ECO Animal Health are currently priced at 365p. At that level they are trading at 21.92% discount to the analyst consensus target price of 467.47.

Analysts covering ECO Animal Health currently have a consensus Earnings Per Share (EPS) forecast of 0.1106 for the next financial year.

How can I tell whether the ECO Animal Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ECO Animal Health. Over the past six months, the relative strength of its shares against the market has been 39.44%. At the current price of 365p, shares in ECO Animal Health are trading at 32.81% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ECO Animal Health PE Ratio?

The ECO Animal Health PE ratio based on its reported earnings over the past 12 months is 70.96. The shares are currently trading at 365p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of ECO Animal Health?

ECO Animal Health's management team is headed by:

Marc Loomes - CEO
Julia Trouse - SEC
Anthony Rawlinson - NID
Andrew Jones - NEC
Christopher Wilks - CFO
Frank Armstrong - NED
Who are the major shareholders of ECO Animal Health?

Here are the top five shareholders of ECO Animal Health based on the size of their shareholding:

AXA Investment Managers UK Ltd. Investment Advisor/Hedge Fund
Percentage owned: 10.48% (7.09m shares)
Lawrence (Peter Anthony) Individual Investor
Percentage owned: 10.28% (6.96m shares)
Danske Bank Asset Management Investment Advisor
Percentage owned: 6.35% (4.30m shares)
MI Chelverton UK Equity Growth Fund Mutual Fund
Percentage owned: 5.91% (4.00m shares)
Chelverton Asset Management Ltd. Investment Advisor
Percentage owned: 5.91% (4.00m shares)
Similar to EAH
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.